Director Edward J. Ludwig buys 3,580 Boston Scientific (BSX) shares in open market

Rhea-AI Filing Summary

BOSTON SCIENTIFIC CORP director Edward J. Ludwig made an open-market purchase of 3,580 shares of Common Stock at $56.68 per share. The transaction occurred on May 20, 2026 and increased his direct ownership to 25,359 shares following the trade.

Insider Trade Summary

Net Buyer: 3,580 shares ($202,914)

Net Buy 1 txn

Insider LUDWIG EDWARD J

Role null

Bought 3,580 shs ($203K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	3,580	$56.68	$203K

Holdings After Transaction: Common Stock — 25,359 shares (Direct, null)

Footnotes (1)

Key Figures

Shares purchased: 3,580 shares Purchase price: $56.68 per share Shares owned after: 25,359 shares +1 more

4 metrics

Shares purchased 3,580 shares Open-market purchase of Common Stock on May 20, 2026

Purchase price $56.68 per share Price for 3,580 Common Stock shares

Shares owned after 25,359 shares Direct ownership following the transaction

Net buy shares 3,580 shares Net change in buy/sell activity in this Form 4

Key Terms

open-market purchase, Common Stock, Form 4

3 terms

open-market purchase financial

"transaction_action: "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LUDWIG EDWARD J

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MASSACHUSETTS 01752-1234

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		P		3,580	A	$56.68	25,359	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Susan Thompson, Attorney-in-Fact	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Boston Scientific (BSX) report for Edward J. Ludwig?

Boston Scientific reported that director Edward J. Ludwig completed an open-market purchase of 3,580 shares of Common Stock. The transaction was recorded as a Form 4 filing and reflects a direct increase in his personal share ownership in the company.

At what price did Edward J. Ludwig buy Boston Scientific (BSX) shares?

Edward J. Ludwig bought Boston Scientific Common Stock at $56.68 per share. This price is reported as the transaction price per share for his open-market purchase of 3,580 shares, as disclosed in the Form 4 insider trading report.

How many Boston Scientific (BSX) shares does Edward J. Ludwig own after this trade?

After the reported transaction, Edward J. Ludwig directly owns 25,359 shares of Boston Scientific Common Stock. This post-transaction holding reflects his updated direct ownership position following the purchase of 3,580 shares on May 20, 2026.

Was the recent Boston Scientific (BSX) insider trade a purchase or a sale?

The recent Boston Scientific insider trade by director Edward J. Ludwig was a purchase. The Form 4 classifies it as an open-market purchase transaction, coded “P,” with 3,580 shares acquired and no corresponding share sales reported in the same filing.

Did Edward J. Ludwig’s Boston Scientific (BSX) trade involve any derivative securities?

The disclosed transaction for Edward J. Ludwig involved only non-derivative Common Stock. The filing shows an open-market purchase of 3,580 shares and lists no derivative securities or option exercises in the derivativeSummary section of the Form 4.